New clinical trial designs for evaluation of antimicrobial agents Speakers: David Paterson, Director, University of Queensland Centre for Clinical Research (Australia) Julie Marsh, Biostatistical Lead, Wesfarmers Centre of Vaccines and […]
This workshop will explore combination therapy, from treatment to diagnostics. This will be a hands-on workshop with lectures and ample time for discussions. This workshop will be held online and […]
GARDP organises a live webinar that will feature presentations on the following topics: – The AMR Studio: a multidisciplinary podcast on antimicrobial resistance (Eva Garmendia) – Resources by the British […]
World Microbe Forum, a collaboration between the American Society for Microbiology (ASM), Federation of European Microbiological Societies (FEMS), and several other societies, is breaking barriers to sharing science and addressing the most pressing […]
As of July 2021, GARDP will be launching a new series of webinars: AMR Discussions. In the first of these, the question will be addressed of how to balance equitable […]
The 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) will take place online from 9 – 12 July 2021. This is the first time the event will take […]
Register here: https://register.gotowebinar.com/register/1374429533352058896?source=ENABLE Speakers: Tejas Bouklas, Assistant Professor, The State University of New York College at Old Westbury, USA Maurizio Del Poeta, Distinguished Professor, The State University of New York at Stony […]
Each day will offer an AMR briefing session in the afternoon (starting at 2pm CET) on a dedicated topic, including live speakers, high-level panel discussions, and interactive exchange with the audience.
Speakers: Evelina Tacconelli, Director of the Infectious Diseases Unit, Verona University Hospital and Head of Infectious Disease, Department of Diagnostic and Public Health, University of Verona, Italy Moderator: Gavin Barlow, Senior […]
As multi-drug resistant bacteria become increasingly threatening to global public health and existing antibiotics are becoming ineffective, the global community of public and private organizations and life science innovators are […]
